Relugolix vs. Leuprolide in Combination with Radiotherapy for Localized Prostate Cancer: Analysis of Patient-Reported Quality of Life in a Randomized Trial
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S173
DOI: 10.1016/j.ijrobp.2026.06.277 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von N. Sebastian und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sebastian, N., Zheng, B., Goyal, S., Liu, Y., Dhere, V., Hershatter, B., Patel, P., Sanda, M., Jani, A., & Patel, S. (2026). Relugolix vs. Leuprolide in Combination with Radiotherapy for Localized Prostate Cancer: Analysis of Patient-Reported Quality of Life in a Randomized Trial. International Journal of Radiation Oncology*Biology*Physics, 126(1), S173. https://doi.org/10.1016/j.ijrobp.2026.06.277
Vancouver
Sebastian N, Zheng B, Goyal S, Liu Y, Dhere V, Hershatter B, et al. Relugolix vs. Leuprolide in Combination with Radiotherapy for Localized Prostate Cancer: Analysis of Patient-Reported Quality of Life in a Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S173. doi:10.1016/j.ijrobp.2026.06.277
BibTeX
@article{Sebastian2026,
author = {Sebastian, N. and Zheng, B. and Goyal, S. and Liu, Y. and Dhere, V.R. and Hershatter, B. and Patel, P.R. and Sanda, M.G. and Jani, A. and Patel, S.A.},
title = {Relugolix vs. Leuprolide in Combination with Radiotherapy for Localized Prostate Cancer: Analysis of Patient-Reported Quality of Life in a Randomized Trial},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S173},
doi = {10.1016/j.ijrobp.2026.06.277}
}
EUVIMED